Fibroblast Growth Factor ResearchBladder and Urothelial Cancer TreatmentsUrinary and Genital Oncology Studies

To evaluate the usefulness of FGFR3, HRAS, KRAS, NRAS, p53, and PIK3CA mutations in urothelial carcinoma cases: A pilot study

Gaurav Pratap Singh Gahlot, Beenu Singh Gahlot, Blessy Mathew, Bishnu Raj, Kavita Sahai, B. Nambiar, Tathagata Chatterjee, D. Gupta, Monika Aggarwal, Metaanksha Ahuja

2026.5.1Medical Journal Armed Forces India

DOI: 10.1016/j.mjafi.2026.02.012

Abstract

Abstract is not available.

Citation format

GAHLOT, Gaurav Pratap Singh, et al. To evaluate the usefulness of FGFR3, HRAS, KRAS, NRAS, p53, and PIK3CA mutations in urothelial carcinoma cases: A pilot study. Medical Journal Armed Forces India, 2026.